文献速递垂体与肾上腺疾病

东南亚地区原发性醛固酮增多症管理中的医疗保健挑战

Health Care Challenges in the Management of Primary Aldosteronism in Southeast Asia.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

该研究通过问卷调查研究东南亚国家联盟(ASEAN)地区管理原发性醛固酮增多症(PA)的医疗资源可及性和可负担性。结果显示,尽管所有参与国均开展醛固酮-肾素比值筛查,但仅6国常规进行确诊试验,7国不常规开展肾上腺静脉采血(AVS),在6国AVS联合肾上腺切除术的费用超过人均年国内生产总值的30%。结论认为大量人口无法获得PA优化管理所需的医疗资源,需努力改善医疗可及性和可负担性,未来指南修订需考虑这些限制。

要点

  • 在9个ASEAN成员国中,所有国家均进行醛固酮-肾素比值筛查,但仅6国常规开展确诊试验。
  • 在6个国家中,AVS联合肾上腺切除术的费用超过人均年国内生产总值的30%。

核心结论

  • 大量人口目前无法获得原发性醛固酮增多症优化管理所需的医疗资源。
  • 需要加大努力改善医疗可及性和可负担性。
  • 未来原发性醛固酮增多症指南修订可能需要考虑这些限制。

研究设计与样本

  • 采用基于问卷的调查,对象为管理原发性醛固酮增多症的专科医生,评估检查和治疗的可及性与可负担性。
  • 人口和收入状况数据取自国家人口普查和登记系统。
  • 共有9个东盟成员国、48名受访者参与。

主要发现

  • 所有参与国均进行醛固酮-肾素比值筛查,但仅6个国家因缺乏设施和本地检测方法及费用限制而常规进行确诊试验。
  • 检测方法仅在4个国家本地可用,部分中心的检测周转时间超过3周。
  • 大多数患者可获得肾上腺切除术和药物治疗。
  • 在6个国家中,肾上腺静脉采血和肾上腺切除术 combined 的费用超过人均年国内生产总值的30%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: While guidelines have been formulated for the management of primary aldosteronism (PA), following these recommendations may be challenging in developing countries with limited health care access. OBJECTIVE: We aimed to assess the availability and affordability of health care resources for managing PA in the Association of Southeast Asian Nations (ASEAN) region, which includes low-middle-income countries. METHODS: We instituted a questionnaire-based survey to specialists managing PA, assessing the availability and affordability of investigations and treatment. Population and income status data were taken from the national census and registries. RESULTS: Nine ASEAN country members (48 respondents) participated. While screening with aldosterone-renin ratio is performed in all countries, confirmatory testing is routinely performed in only 6 countries due to lack of facilities and local assays, and cost constraint. Assays are locally available in only 4 countries, and some centers have a test turnaround time exceeding 3 weeks. In 7 countries (combined population of 442 million), adrenal vein sampling (AVS) is not routinely performed due to insufficient radiological facilities or trained personnel, and cost constraint. Most patients have access to adrenalectomy and medications. In 6 countries, the cost of AVS and adrenalectomy combined is more than 30% of its annual gross domestic product per capita. While most patients had access to spironolactone, it was not universally affordable. CONCLUSION: Large populations currently do not have access to the health care resources required for the optimal management of PA. Greater efforts are required to improve health care access and affordability. Future guideline revisions for PA may need to consider these limitations.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Sukor N, Sunthornyothin S, Tran TV, et al. Health Care Challenges in the Management of Primary Aldosteronism in Southeast Asia. J Clin Endocrinol Metab. 2024. PMID: 38261997. doi:10.1210/clinem/dgae039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。